BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37977035)

  • 21. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
    Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
    Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
    He Z; Yi J; Liu X; Chen J; Han S; Jin L; Chen L; Song H
    Mol Cancer; 2016 Jun; 15(1):51. PubMed ID: 27358073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
    Zhang J; Liu S; Zhang D; Ma Z; Sun L
    J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
    Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
    Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
    Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
    Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of Ras-associated binding protein 23 knockdown on the migration and invasion of esophageal squamous cell carcinoma cells and its mechanism].
    Ma G; Liang H; Zhang RP; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):108-117. PubMed ID: 38418184
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
    Zhu ZQ; Hu HF; Zheng XY; Wang F
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
    [No Abstract]   [Full Text] [Related]  

  • 36. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.
    Chen Q; Zhang L; Wan C; Yang B; Kong X; Xu X; Gu Y; Wang C; Liu X; Ding Q; Zhu L; Li Y; Wang B; Zhong W
    Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37203411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.
    Ou L; Wei Z; Xu J; Li W; Zhou Y; Wang Y; Shi B
    Ann Clin Lab Sci; 2022 Mar; 52(2):260-268. PubMed ID: 35414505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidic acid promotes ESCC progression by increasing the level of CCL2 secreted by esophageal epithelial cells.
    Ma H; Ma X; Qi L; Zhang Q; Wang T; Guo Q; Li P; Zhang S; Liu S
    J Gene Med; 2024 Jun; 26(6):e3708. PubMed ID: 38837511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.